Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study by Papp, K, MD, Bissonnette, R, MD, Rosoph, L, MD, Wasel, N, MD, Lynde, CW, MD, Searles, G, MD, Shear, NH, Prof, Huizinga, RB, MSc, Maksymowych, WP, Prof

Get full text

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled t... by Leonardi, Craig L, Prof, Kimball, Alexa B, MD, Papp, Kim A, MD, Yeilding, Newman, MD, Guzzo, Cynthia, MD, Wang, Yuhua, PhD, Li, Shu, MS, Dooley, Lisa T, DrPH, Gordon, Kenneth B, Dr

Get full text

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled t... by Papp, Kim A, Dr, Langley, Richard G, MD, Lebwohl, Mark, Prof, Krueger, Gerald G, Prof, Szapary, Philippe, MD, Yeilding, Newman, MD, Guzzo, Cynthia, MD, Hsu, Ming-Chun, PhD, Wang, Yuhua, PhD, Li, Shu, MS, Dooley, Lisa T, DrPH, Reich, Kristian, Prof

Get full text